Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Review Article

SRP. 2012; 3(1): 1-3


Is Hypertriglyceridemia a Key Detrimental Factor or Associative Triggering Factor for Cardiovascular Abnormalities?

Pitchai Balakumar, Lalita Babbar, Sanjeev Kalra, Nanjaian Mahadevan, Seetharaman Sritharan, Pawan Krishan.

Abstract
Elevation of fasting plasma triglycerides above the normal level (150 mg/dL) is an indication of
hypertriglyceridemia (borderline high, 150–199 mg/dL; high, 200-499 mg/dL; very high, above
500 mg/dL). A plethora of experimental and clinical studies evidenced a perceptible association
between hypertriglyceridemia and cardiovascular disease. Hypertriglyceridmia could lead to
endothelial dysfunction, atherosclerosis, hypertension, and ischemic heart disease. In addition,
studies have demonstrated the myocardial susceptibility to ischemia-reperfusion injury in the
hypertriglyceridemic condition. Importantly, hypertriglyceridemia alone may cause cardiovascular
abnormalities like atherosclerosis even in absence of hypercholesterolemia. It is worth-mentioning
that a pharmacological reduction in triglyceride levels diminishes the cardiovascular disease
pathogenesis. It is a subject of contemporary interest to detail whether hypertriglyceridemia a
key detrimental factor or an associative triggering factor for cardiovascular abnormalities. This
review will discuss the potential role of hypertriglyceridemia in the pathogenesis of cardiovascular
disorders.

Key words: Atherosclerosis, coronary artery disease, endothelial dysfunction, hypertension, hypertriglyceridemia, ischemic myocardial injury



Similar Articles

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Presenilin mutations and their impact on neuronal differentiation in Alzheimer's disease.
Hernandez-Sapiens MA, Reza-Zaldívar EE, Márquez-Aguirre AL, Gómez-Pinedo U, Matias-Guiu J, Cevallos RR, Mateos-Díaz JC, Sánchez-González VJ, Canales-Aguirre AA
Neural regeneration research. 2022; 17(1): 31-37

The anatomical, electrophysiological and histological observations of muscle contraction units in rabbits: a new perspective on nerve injury and regeneration.
Xu TM, Chen B, Jin ZX, Yin XF, Zhang PX, Jiang BG
Neural regeneration research. 2022; 17(1): 228-232

Inhibition of LncRNA Vof-16 expression promotes nerve regeneration and functional recovery after spinal cord injury.
Zhang XM, Zeng LN, Yang WY, Ding L, Chen KZ, Fu WJ, Zeng SQ, Liang YR, Chen GH, Wu HF
Neural regeneration research. 2022; 17(1): 217-227

extract promotes M2 polarization and reduces oligomeric amyloid-β-induced inflammatory reactions in microglial cells.
Sun ZQ, Liu JF, Luo W, Wong CH, So KF, Hu Y, Chiu K
Neural regeneration research. 2022; 17(1): 203-209


Full-text options


Add your Article(s) to Indexes
• CiteIndex: Articles & Statistics







Advertisement
American Journal of Diagnostic Imaging

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.